コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 imics and decreased nuclear translocation of interferon regulatory factors.
2 surprisingly, transcriptional activation by interferon regulatory factors.
3 on and was associated with downregulation of interferon regulatory factor 1 (IRF-1) and decreased lev
4 ion and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of
5 ving inhibition of the transcription factors interferon regulatory factor 1 (IRF-1) and upstream stim
6 ion of type I interferon (IFN) signaling and interferon regulatory factor 1 (IRF-1) expression is req
9 ion and joint-associated swelling.IMPORTANCE Interferon regulatory factor 1 (IRF-1) is a transcriptio
11 Here we report that the transcription factor interferon regulatory factor 1 (IRF-1) is required for c
12 al deficiency of antiviral tumor-suppressive interferon regulatory factor 1 (IRF-1) selectively promo
13 growth factor beta (TGF-beta) signaling, and interferon regulatory factor 1 (IRF-1) transactivation.
14 of viral double-stranded RNA, depends on the interferon regulatory factor 1 (IRF1) and IRF2 transcrip
15 b which has full enhancer activity and binds interferon regulatory factor 1 (IRF1) and nuclear factor
16 ransitioned cells are defective in inducible interferon regulatory factor 1 (IRF1) expression by occl
17 association in European Americans was at the interferon regulatory factor 1 (IRF1) locus on 5q31.1.
19 is highly dynamic at the STAT1 target gene, interferon regulatory factor 1 (IRF1), suggesting that a
22 man herpesvirus 8 (HHV-8) gene product viral interferon regulatory factor 1 (vIRF-1) is targeted to m
26 immunity to dietary antigen was dependent on interferon regulatory factor 1 and dissociated from supp
27 rafficking and macrophage recruitment (e.g., interferon regulatory factor 1, CD97), adaptive immune r
30 lost its transient nature in the absence of interferon-regulatory factor 1 (IRF-1), a transcription
31 expression of the transcription factor IRF1 (interferon-regulatory factor 1), the roles of IRF1 in im
35 ism by HCV NS5A, leading to activation of an interferon regulatory factor-1 (IRF1)-driven cell intrin
36 saccharide-induced nuclear factor-kappaB and interferon regulatory factor-1 activation in RAW 264.7 m
38 nitric oxide synthase and cyclooxygenase-2, interferon regulatory factor-1, interferon-inducible pro
41 network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription fact
42 ate that KRAS(*) represses the expression of interferon regulatory factor 2 (IRF2), which in turn dir
43 a-replication factor C3 (RFC3), FAM111A, and interferon regulatory factor 2 (IRF2)-were confirmed by
44 ess expression of the transcription cofactor interferon regulatory factor 2-binding protein 2 (IRF2BP
47 ator of interferon genes-TANK-binding kinase-interferon regulatory factor 3 (cGAS-STING-TBK1-IRF3) si
49 sponses mediated by the transcription factor interferon regulatory factor 3 (IRF-3) are often vital f
50 actors nuclear factor kappaB (NF-kappaB) and interferon regulatory factor 3 (IRF-3) at a step subsequ
51 n in vitro, class II transactivator (CIITA), interferon regulatory factor 3 (IRF-3), and interferon r
52 actors nuclear factor kappaB (NF-kappaB) and interferon regulatory factor 3 (IRF-3), classically indu
53 -beta (TRIF), TRIF-related adaptor molecule, interferon regulatory factor 3 (IRF-3), receptor-interac
54 hibited poly(I.C)-induced phosphorylation of interferon regulatory factor 3 (IRF-3), which is the key
55 key proapoptotic protein in this pathway is interferon regulatory factor 3 (IRF-3), which upon activ
56 uently, binding of IFI44L to FKBP5 decreased interferon regulatory factor 3 (IRF-3)-mediated and nucl
57 HeLa cells, EV68 inhibits poly(I.C)-induced interferon regulatory factor 3 (IRF3) activation and bet
58 e, we report that exogenous IL-1beta induces interferon regulatory factor 3 (IRF3) activation in huma
59 (IFN-I) production through inhibition of the interferon regulatory factor 3 (IRF3) activation pathway
60 1 and -2 was required for phosphorylation of interferon regulatory factor 3 (IRF3) and accumulation o
61 f cytokines via TANK binding kinase 1 (TBK1)/interferon regulatory factor 3 (IRF3) and inhibitor of n
62 s) required for initiating the activation of interferon regulatory factor 3 (IRF3) and interferon (IF
64 ents and activation of transcription factors interferon regulatory factor 3 (IRF3) and NF-kappaB, STI
66 r proteins leading to activation of both the interferon regulatory factor 3 (IRF3) and nuclear factor
67 in turn activates the transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor
69 -dependent phosphorylation and activation of Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquit
70 TBK1 phosphorylates the transcription factor Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquit
71 then bind to a positively charged surface of interferon regulatory factor 3 (IRF3) and thereby recrui
74 nse to viral infection by degradation of the interferon regulatory factor 3 (IRF3) has been subject o
75 of the immune signaling transcription factor interferon regulatory factor 3 (IRF3) in response to cyt
76 ndrial antiviral signaling protein (MAVS) or interferon regulatory factor 3 (IRF3) in the IFN inducti
80 ic acid (S386D) in ANDV N robustly inhibited interferon regulatory factor 3 (IRF3) phosphorylation an
81 y and confirmed that these miRNAs potentiate interferon regulatory factor 3 (IRF3) phosphorylation an
82 the interferon beta (IFN-beta) promoter and interferon regulatory factor 3 (IRF3) phosphorylation.
86 ntly phosphorylates the transcription factor interferon regulatory factor 3 (IRF3) to promote interfe
87 antagonist capable of blocking activation of interferon regulatory factor 3 (IRF3) via the retinoic a
88 sible for HIV-1 targeting and degradation of interferon regulatory factor 3 (IRF3), a central transcr
90 cells causes partial proteolytic cleavage of interferon regulatory factor 3 (IRF3), a key transcripti
91 hondrial antiviral signaling protein (MAVS), interferon regulatory factor 3 (IRF3), or Interferon-alp
92 uit TANK-binding kinase 1 (TBK1) to activate interferon regulatory factor 3 (IRF3), resulting in prod
93 E) inhibits TBK1-mediated phosphorylation of interferon regulatory factor 3 (IRF3), which is essentia
94 s alcoholic liver disease (ALD) and that the interferon regulatory factor 3 (IRF3),a transcription fa
95 rom the site of inoculation independently of interferon regulatory factor 3 (IRF3)-, IRF7-, and IFNAR
96 R OF INTERFERON GENES (STING), activating an INTERFERON REGULATORY FACTOR 3 (IRF3)-mediated immune re
104 IFN-beta promoter when it was stimulated by interferon regulatory factor 3 (IRF3)/5D or its upstream
106 anscription factors was increased, including interferon regulatory factor 3 and 7 (IRF-3 and IRF-7) a
108 ciated with increased baseline expression of interferon regulatory factor 3 and 7 mRNAs and productio
109 985 inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiprolifer
111 l28ra(-/-)), and mice with disruption of the interferon regulatory factor 3 gene (Irf3(-/-)), with or
113 etion of the downstream transcription factor interferon regulatory factor 3 resulted in reduced induc
114 ding activation of the TANK binding kinase 1/interferon regulatory factor 3 type I interferon pathway
115 f interferon genes - tank-binding kinase 1 - interferon regulatory factor 3) pathway, shedding light
116 1)-AKT (AKT serine/threonine kinase 1)-IRF3 (interferon regulatory factor 3) signaling cascade leadin
117 hatase 2A (PP2A) as a deactivator of phospho-interferon regulatory factor 3, the key transcription fa
118 s in which it activated STING and its target interferon regulatory factor 3, which directly induced m
123 on and decreased the nuclear accumulation of interferon regulatory factors 3 and 7 (IRF3 and -7) and
124 ase beta (IKKB), IkappaB kinase iota (IKKI), interferon regulatory factors 3 and 7, and rhinovirus in
126 articular, expression and phosphorylation of interferon-regulatory factor 3 (IRF3) was decreased in E
127 this study we have defined the mechanisms of interferon regulatory factor-3 (IRF-3) signaling in prim
128 increased PTEN/TLR4 (Toll-like receptor 4), interferon regulatory factor-3 (IRF3), nuclear factor ka
129 plex virus (HSV)-infected cells and initiate interferon regulatory factor-3 signaling, but it has bee
130 or B cell development and function, cellular interferon regulatory factor 4 (c-IRF4) directly regulat
134 es myeloid and B-cell leukemia by inhibiting interferon regulatory factor 4 (IRF4) but through distin
136 rtance of the oncogenic transcription factor interferon regulatory factor 4 (IRF4) in hematological m
143 d chemokine production, lung histopathology, interferon regulatory factor 4 (IRF4) mRNA expression, a
144 microbial products, the transcription factor interferon regulatory factor 4 (IRF4) promotes regulator
146 T) proteins and on the cooperative action of interferon regulatory factor 4 (IRF4) with activator pro
147 type is accompanied by a higher induction of interferon regulatory factor 4 (IRF4), a transcriptional
149 et is controlled by the transcription factor interferon regulatory factor 4 (IRF4), which is required
152 ated STAT3 and reduced protein expression of interferon regulatory factor 4 and B-cell lymphoma 6 (BC
153 n and small molecule inhibition downregulate interferon regulatory factor 4 and MYC, and provides an
154 on loop mediated by the transcription factor interferon regulatory factor 4 and the chemokine recepto
155 induction of the transcription factors IRF4 (interferon regulatory factor 4) and Bcl6, driving both e
156 c deletion of the transcription factor IRF4 (interferon regulatory factor 4) in Tcl-1 transgenic mice
157 of lenalidomide are associated with reduced interferon regulatory factor 4, a downstream target of c
158 mide treatment resulted in downregulation of interferon regulatory factor 4, a transcription factor f
159 hemistry for MYC, BCL2, CD10, BCL6, and MUM1/interferon regulatory factor 4, and fluorescent in situ
160 sion of CCAAT/enhancer-binding protein-beta, interferon regulatory factor 4, and peroxisome prolifera
161 cluding CCAAT/enhancer-binding protein-beta, interferon regulatory factor 4, and peroxisome prolifera
162 tion was found to be driven by 2 variants of interferon regulatory factor 4-dependent dermal type 2 c
165 revious study found microglial expression of interferon regulatory factor 5 (IRF5) and IRF4 was relat
170 Similar to Puma, the transcription factor interferon regulatory factor 5 (Irf5) has been reported
171 hether silencing of the transcription factor interferon regulatory factor 5 (IRF5) in cardiac macroph
179 f p53-mediated LMP1 expression, we find that interferon regulatory factor 5 (IRF5), a direct target o
180 4 kinase activity controls the activation of interferon regulatory factor 5 (IRF5), a transcription f
182 henotype due to decreased P-STAT1 (Y701) and interferon regulatory factor 5 compared with NOD mice.
183 Mechanistically, lack of IRAK4 resulted in interferon regulatory factor 5 homodimerization via redu
184 nanoparticles formulated with mRNAs encoding interferon regulatory factor 5 in combination with its a
185 crosis factor-alpha, the chemokine CCL2, and interferon regulatory factor-5 (IRF5), a marker of infla
190 tor-interacting protein kinase 4 (RIPK4) and interferon regulatory factor 6 (IRF6) are critical regul
191 actor beta (TGFbeta) signaling molecules and interferon regulatory factor 6 (Irf6) have been identifi
193 ion of canonical WNT signaling perturbed p63/interferon regulatory factor 6 (p63/IRF6) signaling, res
195 N-lambda expression by hMPV was dependent on interferon regulatory factor 7 (IRF-7) expression but no
198 interferon regulatory factor 3 (IRF-3), and interferon regulatory factor 7 (IRF-7) were not required
199 C in LMP1 signaling leading to NF-kappaB and interferon regulatory factor 7 (IRF7) activation has not
200 f (RHIM) domains of TRIF and RIP1 to disrupt interferon regulatory factor 7 (IRF7) activity, a critic
201 ander cells resist STAT1 phosphorylation and interferon regulatory factor 7 (IRF7) induction in respo
202 ly shown that ORF45 suppresses activation of interferon regulatory factor 7 (IRF7), a crucial regulat
204 nate antiviral immunity by downregulation of interferon regulatory factor 7 (IRF7), an immune factor
205 r MyD88, the downstream transcription factor interferon regulatory factor 7 (IRF7), and type I interf
207 n to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I i
209 anistically, IL-33 downregulated viperin and interferon regulatory factor 7 gene expression and rapid
213 cated suppression of antiviral host factors (interferon regulatory factor 7, CXCL10 [gamma interferon
214 IRF7, which encodes the transcription factor interferon regulatory factor 7, in an otherwise healthy
215 ce of hyperconnected hub nodes, most notably interferon regulatory factor 7, which was identified as
216 Foxp3(+) Tregs showed reduced expression of interferon regulatory factor 8 (IRF-8)/aldehyde dehydrog
217 cent epidemiological studies have identified interferon regulatory factor 8 (IRF8) as a susceptibilit
219 fied novel associations in the chromosome 16 interferon regulatory factor 8 (IRF8) gene (P-value = 2.
227 epressive effect of the transcription factor interferon regulatory factor 8 (IRF8), which is highly e
228 eded the genome-wide significance threshold: interferon regulatory factor 8 (IRF8; rs11644034; p(meta
232 rise from perturbations in the regulation of interferon regulatory factor-8 (IRF-8), an integral tran
234 feron-stimulated gene factor 3 [ISGF3]) with interferon regulatory factor 9 (IRF9) and translocate to
235 d activator of transcription (STAT) 1 and 2, interferon regulatory factor 9, N-myc and STAT interacto
239 ed that IRG1 is not an miR93 target but that interferon regulatory factor-9, which can regulate IRG1
240 were conducted to examine the role of miR93-interferon regulatory factor-9-immunoresponsive gene-1 (
241 ulator (NEMO), an essential adaptor bridging interferon-regulatory factor and NF-kappaB activation.
242 cally, we demonstrated that TRIM29 inhibited interferon-regulatory factors and signaling via the tran
243 iallelic mutations in IRF8, which encodes an interferon regulatory factor, as a cause of familial NK
244 ially regulated cell genes identified an ETS-interferon regulatory factor composite element motif tha
245 ent expression of DNA-dependent activator of interferon regulatory factors (DAI, also known as ZBP1 o
246 ceptor 9 (TLR-9), DNA-dependent activator of interferon-regulatory factors (DAI), and absent in melan
247 h these receptors stimulates, in most cases, interferon regulatory factor-dependent type I IFN synthe
249 gulators of type I and type III interferons, interferon regulatory factor (IRF) 3 and IRF7, were sign
250 kinase-1 (TBK1)-dependent phosphorylation of interferon regulatory factor (IRF) 3 and transcription o
253 e, using 6-week-old mice triply deficient in interferon regulatory factor (IRF) as a model, we show t
254 er of adipocyte inflammation, members of the interferon regulatory factor (IRF) family may also play
257 Here, we showed that IRF2, a member of the interferon regulatory factor (IRF) family of transcripti
260 that secretes excess c-di-AMP activates the interferon regulatory factor (IRF) pathway with enhanced
262 ex pattern of deregulated TFs, we discovered interferon regulatory factor (IRF) sites among the top e
263 riven by nuclear factor kappa B (NF-kappaB), interferon regulatory factor (IRF), and the signal trans
266 ctly targeting high mobility group box-1 and interferon regulatory factor (IRF)-5, preventing activat
267 iethylhexyl phthalate suppressed CpG-induced interferon regulatory factor (IRF)-7 expression by suppr
268 e shared genes showed sequences required for interferon regulatory factor (IRF)-mediated transcriptio
271 gnaling pathways and cause activation of the interferon regulatory factor (IRF-3) transcription facto
273 f transcription 1 [STAT1], protein kinase R, interferon regulatory factors (IRF) IRF-1, IRF-3, IRF-5,
275 of the PD-L1 transcriptional repressors, the interferon regulatory factors IRF2 and IRF2BP2, which li
276 with ELF4 increases the binding affinity of interferon regulatory factors IRF3 and IRF7, which is me
277 s the activation of the transcription factor interferon regulatory factor (IRF4), which, along with t
278 The restrictive effects of IFN-I require the interferon regulatory factor IRF5, which upregulates gen
279 )-STING pathway and subsequent activation of interferon regulatory factors (IRFs) 3 and 7, type I int
280 ron (IFN) signalling, including upregulating interferon regulatory factors (IRFs) and downregulating
281 ron response that could be driven in part by interferon regulatory factors (IRFs) and increased NF-ka
282 ositive-feedback loops mediated by inducible interferon regulatory factors (IRFs) and retinoic acid i
287 y shown that three KSHV homologs of cellular interferon regulatory factors (IRFs), known as viral IRF
288 known to encode viral homologues to cellular interferon regulatory factors (IRFs), known as vIRFs.
289 at they express viral homologues to cellular interferon regulatory factors (IRFs), termed viral IRFs
290 eir expression of viral homologs of cellular interferon regulatory factors (IRFs), termed viral IRFs
291 ular patterns, and signal downstream through interferon regulatory factors (IRFs), transcription fact
293 e, cyclooxygenase-2) and a MyD88-independent interferon regulatory factor-mediated pathway that regul
294 in melanoma 2 and DNA-dependent activator of interferon regulatory factor) opened a new paradigm: Nuc
298 ies, including beta-catenin, Ap-1, NFkappaB, interferon regulatory factors, STATs, JUN, and p53.
299 man herpesvirus 8 (HHV-8) encodes four viral interferon regulatory factors (vIRFs 1 to 4), all of whi
300 demonstrated that DNA-dependent activator of interferon regulatory factors/Z-DNA binding protein 1 (D